![Andrea DiFabio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea DiFabio
Algemeen Adviseur bij
XENON PHARMACEUTICALS INC.
Vermogen: 440 688 $ op 30-06-2026
Profiel
Andrea DiFabio is Secretary & Chief Legal Officer at Xenon Pharmaceuticals, Inc. since 2022.
Former roles include Secretary, Chief Legal & Administrative Officer at Repertoire Immune Medicines, Inc. from 2020 to 2022; Secretary, Chief Legal Officer & Executive VP at Bioverativ, Inc. from 2016 to 2018; Chief Research & Business Development Counsel at Biogen, Inc. from 2006 to 2017; Chief Legal Officer at Codiak BioSciences, Inc.; Vice President & Deputy General Counsel at PAREXEL International Corp.; and Director-Northeast Chapter at the Association of Corporate Counsel.
Education includes undergraduate studies at Boston University and graduate studies at Northeastern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-04-2026 | 7.301 ( 0,01% ) | 440 688 $ | 30-06-2026 |
Actieve functies van Andrea DiFabio
| Bedrijven | Functie | Begin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Algemeen Adviseur | 07-11-2022 |
Eerdere bekende functies van Andrea DiFabio
| Bedrijven | Functie | Einde |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Hoofd Administratief Officier | 01-10-2022 |
| BIOVERATIV INC | Algemeen Adviseur | 01-06-2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01-02-2017 |
| CODIAK BIOSCIENCES | Algemeen Adviseur | - |
Association of Corporate Counsel
 Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Corporate Officer/Principal | - |
Opleiding van Andrea DiFabio
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
91
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Corporate Counsel
Association of Corporate Counsel Miscellaneous Commercial ServicesCommercial Services Operates as a business professionals association | Commercial Services |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
